THE YEAR IN SHORT

AddLife 2020

The COVID-19 pandemic that hit the world in 2020 led to strong demand in diagnostics and medical technology. Sales increased by 52 percent, of which organic growth amounted to 38 percent. During the year, we made six acquisitions with a total annual turnover of approximately SEK 650 million.

The significant increase in sales in combination with continued good cost control led to a positive earnings effect where EBITA increased by 163 percent compared with 2019. The exceptional result has generated a strong positive operating cash flow, which enables further investments in acquisitions and development for future growth.

The business situation in all markets was affected by the COVID-19 pandemic. The companies within Labtech have delivered large quantities of instruments and COVID-19 tests. At Medtech, demand for personal protective equipment was high during the first half of the year.